|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 Brainsway Ltd. 20-F 12/31/23 110:9.4M Globenewswire Inc./FA |
Document/Exhibit Description Pages Size
1: 20-F Annual or Annual-Transition Report by a Foreign HTML 2.47M
Non-Canadian Issuer
2: EX-2.3 Plan of Acquisition, Reorganization, Arrangement, HTML 84K
Liquidation or Succession
5: EX-13 Annual or Quarterly Report to Security Holders HTML 29K
7: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 51K
Awarded Compensation
3: EX-12.1 Statement re: the Computation of Ratios HTML 32K
4: EX-12.2 Statement re: the Computation of Ratios HTML 32K
6: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 27K
13: R1 Cover HTML 112K
14: R2 Consolidated Statements of Financial Position HTML 96K
15: R3 Consolidated Statements of Comprehensive Loss HTML 65K
16: R4 Consolidated Statements of Comprehensive Loss HTML 33K
(Parenthetical)
17: R5 Consolidated Statements of Changes in Equity HTML 53K
18: R6 Consolidated Statements of Cash Flows HTML 111K
19: R7 General HTML 34K
20: R8 Accounting Policies HTML 84K
21: R9 Significant Accounting Judgments, Estimates and HTML 37K
Assumptions Used in the Preparation of the
Financial Statements
22: R10 Cash and Cash Equivalents and Restricted Cash HTML 39K
23: R11 Short-Term Deposits HTML 35K
24: R12 Trade Receivables, Net HTML 73K
25: R13 Inventory HTML 38K
26: R14 Other Current Assets HTML 36K
27: R15 System Components, Leased Systems, Other Property HTML 186K
and Equipment, Net
28: R16 Other Long-Term Assets HTML 36K
29: R17 Other Accounts Payable HTML 39K
30: R18 Deferred Revenues and Other Liabilities HTML 51K
31: R19 Financial Instruments HTML 120K
32: R20 Employee Benefits and Liabilities HTML 33K
33: R21 Taxes on Income HTML 77K
34: R22 Contingent Liabilities, Commitments and Charges HTML 47K
35: R23 Equity HTML 46K
36: R24 Share-Based Payment HTML 86K
37: R25 Additional Information to the Statements of HTML 136K
Comprehensive Loss
38: R26 Net Loss Per Share HTML 41K
39: R27 Balances and Transactions With Related Parties HTML 82K
40: R28 Accounting Policies (Policies) HTML 112K
41: R29 Accounting Policies (Tables) HTML 41K
42: R30 Cash and Cash Equivalents and Restricted Cash HTML 39K
(Tables)
43: R31 Short-Term Deposits (Tables) HTML 33K
44: R32 Trade Receivables, Net (Tables) HTML 75K
45: R33 Inventory (Tables) HTML 37K
46: R34 Other Current Assets (Tables) HTML 35K
47: R35 System Components, Leased Systems, Other Property HTML 185K
and Equipment, Net (Tables)
48: R36 Other Long-Term Assets (Tables) HTML 35K
49: R37 Other Accounts Payable (Tables) HTML 39K
50: R38 Deferred Revenues and Other Liabilities (Tables) HTML 51K
51: R39 Financial Instruments (Tables) HTML 114K
52: R40 Taxes on Income (Tables) HTML 72K
53: R41 Equity (Tables) HTML 44K
54: R42 Share-Based Payment (Tables) HTML 88K
55: R43 Additional Information to the Statements of HTML 142K
Comprehensive Loss (Tables)
56: R44 Net Loss Per Share (Tables) HTML 40K
57: R45 Balances and Transactions With Related Parties HTML 83K
(Tables)
58: R46 General (Details Narrative) HTML 30K
59: R47 Accounting Policies (Details) HTML 39K
60: R48 Accounting Policies (Details 1) HTML 44K
61: R49 Cash and Cash Equivalents and Restricted Cash HTML 33K
(Details)
62: R50 Cash and Cash Equivalents and Restricted Cash HTML 30K
(Details 1)
63: R51 Short-Term Deposits (Details) HTML 30K
64: R52 Short-Term Deposits (Details Narrative) HTML 30K
65: R53 Trade Receivables, Net (Details) HTML 34K
66: R54 Trade Receivables, Net (Details1) HTML 34K
67: R55 Trade Receivables, Net (Details 2) HTML 52K
68: R56 Inventory (Details) HTML 42K
69: R57 Other Current Assets (Details) HTML 34K
70: R58 System Components, Leased Systems, Other Property HTML 97K
and Equipment, Net (Details)
71: R59 Other Long-Term Assets (Details) HTML 34K
72: R60 Other Accounts Payable (Details) HTML 42K
73: R61 Deferred Revenues and Other Liabilities (Details) HTML 34K
74: R62 Deferred Revenues and Other Liabilities (Details HTML 44K
1)
75: R63 Financial Instruments (Details) HTML 63K
76: R64 Financial Instruments (Details 1) HTML 81K
77: R65 Financial Instruments (Details 2) HTML 33K
78: R66 Financial Instruments (Details Narrative) HTML 32K
79: R67 Employee Benefits and Liabilities (Details HTML 31K
Narrative)
80: R68 Taxes on Income (Details) HTML 45K
81: R69 Taxes on Income (Details 1) HTML 47K
82: R70 Taxes on Income (Details 2) HTML 38K
83: R71 Taxes on Income (Details Narrative) HTML 34K
84: R72 Contingent Liabilities, Commitments and Charges HTML 46K
(Details Narrative)
85: R73 Equity (Details) HTML 32K
86: R74 Equity (Details 1) HTML 35K
87: R75 Share-Based Payment (Details) HTML 31K
88: R76 Share-Based Payment (Details 1) HTML 42K
89: R77 Share-Based Payment (Details 2) HTML 39K
90: R78 Share-Based Payment (Details 3) HTML 49K
91: R79 Share-Based Payment (Details 4) HTML 35K
92: R80 Share-Based Payment (Details Narrative) HTML 34K
93: R81 Additional Information to the Statements of HTML 40K
Comprehensive Loss (Details)
94: R82 Additional Information to the Statements of HTML 33K
Comprehensive Loss (Details 1)
95: R83 Additional Information to the Statements of HTML 41K
Comprehensive Loss (Details 2)
96: R84 Additional Information to the Statements of HTML 37K
Comprehensive Loss (Details 3)
97: R85 Additional Information to the Statements of HTML 49K
Comprehensive Loss (Details 4)
98: R86 Additional Information to the Statements of HTML 44K
Comprehensive Loss (Details 5)
99: R87 Additional Information to the Statements of HTML 44K
Comprehensive Loss (Details 6)
100: R88 Additional Information to the Statements of HTML 47K
Comprehensive Loss (Details 7)
101: R89 Net Loss Per Share (Details) HTML 36K
102: R90 Balances and Transactions With Related Parties HTML 35K
(Details)
103: R91 Balances and Transactions With Related Parties HTML 39K
(Details 1)
104: R92 Balances and Transactions With Related Parties HTML 32K
(Details 2)
105: R93 Balances and Transactions With Related Parties HTML 41K
(Details 3)
107: XML IDEA XML File -- Filing Summary XML 207K
110: XML XBRL Instance -- f20f_031424_htm XML 2.38M
106: EXCEL IDEA Workbook of Financial Report Info XLSX 171K
9: EX-101.CAL XBRL Calculations -- bway-20231231_cal XML 204K
10: EX-101.DEF XBRL Definitions -- bway-20231231_def XML 424K
11: EX-101.LAB XBRL Labels -- bway-20231231_lab XML 922K
12: EX-101.PRE XBRL Presentations -- bway-20231231_pre XML 799K
8: EX-101.SCH XBRL Schema -- bway-20231231 XSD 269K
108: JSON XBRL Instance as JSON Data -- MetaLinks 321± 438K
109: ZIP XBRL Zipped Folder -- 0001171843-24-001696-xbrl Zip 749K
Exhibit 13
CERTIFICATION BY CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BrainsWay Ltd. (the “Company”) on Form 20-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to such officer's knowledge:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: March 28, 2024
| /s/ Hadar Levy |
Chief Executive Officer
| /s/ Ido Marom |
Chief Financial Officer
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/28/24 | None on these Dates | ||
| For Period end: | 12/31/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/12/22 Brainsway Ltd. 20-F 12/31/21 100:8.8M Globenewswire Inc./FA 4/19/21 Brainsway Ltd. 20-F 12/31/20 110:7.9M Globenewswire Inc./FA 2/25/21 Brainsway Ltd. 6-K 2/25/21 4:407K Globenewswire Inc./FA 2/01/19 Bank of New York/ADR Division F-6 3:352K Brainsway Ltd./ADR Emmet Marvin & Mart… LLP 1/14/19 Brainsway Ltd. F-1 21:6.8M Toppan Merrill-FA |